Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149884610> ?p ?o ?g. }
- W2149884610 endingPage "516" @default.
- W2149884610 startingPage "509" @default.
- W2149884610 abstract "Since they were first derived more than three decades ago, embryonic stem cells have been proposed as a source of replacement cells in regenerative medicine, but their plasticity and unlimited capacity for self-renewal raises concerns about their safety, including tumour formation ability, potential immune rejection, and the risk of differentiating into unwanted cell types. We report the medium-term to long-term safety of cells derived from human embryonic stem cells (hESC) transplanted into patients.In the USA, two prospective phase 1/2 studies were done to assess the primary endpoints safety and tolerability of subretinal transplantation of hESC-derived retinal pigment epithelium in nine patients with Stargardt's macular dystrophy (age >18 years) and nine with atrophic age-related macular degeneration (age >55 years). Three dose cohorts (50,000, 100,000, and 150,000 cells) were treated for each eye disorder. Transplanted patients were followed up for a median of 22 months by use of serial systemic, ophthalmic, and imaging examinations. The studies are registered with ClinicalTrials.gov, numbers NCT01345006 (Stargardt's macular dystrophy) and NCT01344993 (age-related macular degeneration).There was no evidence of adverse proliferation, rejection, or serious ocular or systemic safety issues related to the transplanted tissue. Adverse events were associated with vitreoretinal surgery and immunosuppression. 13 (72%) of 18 patients had patches of increasing subretinal pigmentation consistent with transplanted retinal pigment epithelium. Best-corrected visual acuity, monitored as part of the safety protocol, improved in ten eyes, improved or remained the same in seven eyes, and decreased by more than ten letters in one eye, whereas the untreated fellow eyes did not show similar improvements in visual acuity. Vision-related quality-of-life measures increased for general and peripheral vision, and near and distance activities, improving by 16-25 points 3-12 months after transplantation in patients with atrophic age-related macular degeneration and 8-20 points in patients with Stargardt's macular dystrophy.The results of this study provide the first evidence of the medium-term to long-term safety, graft survival, and possible biological activity of pluripotent stem cell progeny in individuals with any disease. Our results suggest that hESC-derived cells could provide a potentially safe new source of cells for the treatment of various unmet medical disorders requiring tissue repair or replacement.Advanced Cell Technology." @default.
- W2149884610 created "2016-06-24" @default.
- W2149884610 creator A5001925974 @default.
- W2149884610 creator A5006317716 @default.
- W2149884610 creator A5011342936 @default.
- W2149884610 creator A5012602381 @default.
- W2149884610 creator A5025464234 @default.
- W2149884610 creator A5034104351 @default.
- W2149884610 creator A5035026607 @default.
- W2149884610 creator A5038698286 @default.
- W2149884610 creator A5039815543 @default.
- W2149884610 creator A5046749065 @default.
- W2149884610 creator A5047748012 @default.
- W2149884610 creator A5059786776 @default.
- W2149884610 creator A5063763099 @default.
- W2149884610 creator A5079231031 @default.
- W2149884610 creator A5086738829 @default.
- W2149884610 creator A5087700840 @default.
- W2149884610 creator A5088358275 @default.
- W2149884610 creator A5091046540 @default.
- W2149884610 date "2015-02-01" @default.
- W2149884610 modified "2023-10-10" @default.
- W2149884610 title "Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies" @default.
- W2149884610 cites W150743151 @default.
- W2149884610 cites W1963486548 @default.
- W2149884610 cites W1971555156 @default.
- W2149884610 cites W1977647023 @default.
- W2149884610 cites W1978198864 @default.
- W2149884610 cites W1993096645 @default.
- W2149884610 cites W1993263656 @default.
- W2149884610 cites W1997833814 @default.
- W2149884610 cites W2002311406 @default.
- W2149884610 cites W2002347162 @default.
- W2149884610 cites W2010977640 @default.
- W2149884610 cites W2011752292 @default.
- W2149884610 cites W2016526297 @default.
- W2149884610 cites W2034018544 @default.
- W2149884610 cites W2035318710 @default.
- W2149884610 cites W2045048112 @default.
- W2149884610 cites W2045899482 @default.
- W2149884610 cites W2048140742 @default.
- W2149884610 cites W2073469611 @default.
- W2149884610 cites W2075661491 @default.
- W2149884610 cites W2078346096 @default.
- W2149884610 cites W2086943348 @default.
- W2149884610 cites W2096060458 @default.
- W2149884610 cites W2111274886 @default.
- W2149884610 cites W2114190644 @default.
- W2149884610 cites W2114914263 @default.
- W2149884610 cites W2137222303 @default.
- W2149884610 cites W2144325994 @default.
- W2149884610 cites W2164826634 @default.
- W2149884610 cites W2411159809 @default.
- W2149884610 cites W4256107229 @default.
- W2149884610 doi "https://doi.org/10.1016/s0140-6736(14)61376-3" @default.
- W2149884610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25458728" @default.
- W2149884610 hasPublicationYear "2015" @default.
- W2149884610 type Work @default.
- W2149884610 sameAs 2149884610 @default.
- W2149884610 citedByCount "1003" @default.
- W2149884610 countsByYear W21498846102014 @default.
- W2149884610 countsByYear W21498846102015 @default.
- W2149884610 countsByYear W21498846102016 @default.
- W2149884610 countsByYear W21498846102017 @default.
- W2149884610 countsByYear W21498846102018 @default.
- W2149884610 countsByYear W21498846102019 @default.
- W2149884610 countsByYear W21498846102020 @default.
- W2149884610 countsByYear W21498846102021 @default.
- W2149884610 countsByYear W21498846102022 @default.
- W2149884610 countsByYear W21498846102023 @default.
- W2149884610 crossrefType "journal-article" @default.
- W2149884610 hasAuthorship W2149884610A5001925974 @default.
- W2149884610 hasAuthorship W2149884610A5006317716 @default.
- W2149884610 hasAuthorship W2149884610A5011342936 @default.
- W2149884610 hasAuthorship W2149884610A5012602381 @default.
- W2149884610 hasAuthorship W2149884610A5025464234 @default.
- W2149884610 hasAuthorship W2149884610A5034104351 @default.
- W2149884610 hasAuthorship W2149884610A5035026607 @default.
- W2149884610 hasAuthorship W2149884610A5038698286 @default.
- W2149884610 hasAuthorship W2149884610A5039815543 @default.
- W2149884610 hasAuthorship W2149884610A5046749065 @default.
- W2149884610 hasAuthorship W2149884610A5047748012 @default.
- W2149884610 hasAuthorship W2149884610A5059786776 @default.
- W2149884610 hasAuthorship W2149884610A5063763099 @default.
- W2149884610 hasAuthorship W2149884610A5079231031 @default.
- W2149884610 hasAuthorship W2149884610A5086738829 @default.
- W2149884610 hasAuthorship W2149884610A5087700840 @default.
- W2149884610 hasAuthorship W2149884610A5088358275 @default.
- W2149884610 hasAuthorship W2149884610A5091046540 @default.
- W2149884610 hasConcept C118487528 @default.
- W2149884610 hasConcept C126322002 @default.
- W2149884610 hasConcept C141071460 @default.
- W2149884610 hasConcept C142724271 @default.
- W2149884610 hasConcept C197934379 @default.
- W2149884610 hasConcept C2776403814 @default.
- W2149884610 hasConcept C2777017193 @default.
- W2149884610 hasConcept C2778024200 @default.
- W2149884610 hasConcept C2778257484 @default.